Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
Biologics Pricing Report
Oral Solid Dose Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
COVID-19 Vaccine
Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine
PAO-M04-20-CL-002
Vaccine
iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute
PR-M04-20-NI-015
Biosimilar
iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
PR-M04-20-NI-014
COVID-19 Vaccine
iBio Announces Advancement of COVID-19 Vaccine Program
PR-M04-20-NI-013
Biosecurity
iBio Joins the Alliance for Biosecurity
PR-M03-20-NI-038
COVID-19 Vaccine
iBio Announces Development of Proprietary COVID-19 Vaccine Candidates
PR-M03-20-NI-037
3D Bioprinting
Facilitating 3D Organ Printing with Plant-Based BioInks
PAP-Q4-19-CL-018
Collaboration
iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage
PR-M09-19-NI-048
Collaboration
iBio and CC-Pharming Expand Business Collaboration in China
PR-M08-19-NI-087
Speed to Market
FastPharming for Speed to Market
PTV-M08-19-BIO-008
Fill-Finish
Reducing Fill-Finish Wait Times
PAO-NI-0719-CL-003
Fill/Finish Agreement
iBio Announces First Agreement for Fill-Finish Services
PR-M06-19-NI-033
Plant-Based Innovation
The Advantage of Plant-Based Expression Solutions Around the Globe
PAO-M05-19-CL-002
Plant-Based Solutions
Plant-based Protein Expression for Rapid, Green Bioprocessing
PAP-Q2-2019-CL-022
